Skip to content

Electrophysiological effects of phencyclidine in the medial prefrontal cortex of the rat.

A Gratton, B J Hoffer, R Freedman

Neuropharmacology September 1987 DOI: 10.1016/0028-3908(87)90087-6 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Single unit recording study Peer reviewed
Population Neurons of the medial prefrontal cortex
Interventions Phencyclidine dopamine (+) PCMP (-) PCMP fluphenazine
Key points Phencyclidine and dopamine depressed the activity of most deep-layer medial prefrontal cortex neurons, while superficial cells showed mixed responses. PCP was 1.5 times more potent than (+) PCMP and 3 times more potent than (-) PCMP, and fluphenazine blocked PCP-induced depressions. The authors argue these data indicate PCP's dopamine-like effects are mediated by dopamine receptors and support specific actions of psychomotor stimulants on A10 dopamine system targets.

Abstract

The effects of local applications of phencyclidine (PCP) and dopamine (DA) on neurons of the medial prefrontal cortex were investigated using single unit recording techniques. The activity of the majority of cells in the deeper layers of the medial prefrontal cortex was depressed by both phencyclidine and DA, whereas increases, as well as decreases, in the firing rates were observed in cells located in the superficial cortical layers. The stereospecificity of the responses of deeper cells to phencyclidine was demonstrated using the enantiomers of 1-(-1-phenylcyclohexyl)-3-methylpiperidine (PCMP). Phencyclidine was found to be 1.5 times more potent than (+) PCMP and 3 times more potent than (-) PCMP. Finally, the DA receptor antagonist fluphenazine, blocked the phencyclidine-elicited depressions of unit activity in the deep prefrontal cortex. Taken together, the data indicate that the DA-like effects of phencyclidine on neurons of the medial prefrontal cortex are mediated by DA receptors and provide pharmacological support for the idea that psychomotor stimulant drugs have specific actions on targets of the ventral tegmental area (A10) dopamine system.

Citations in the library

Explore topics